In renal clear cell carcinoma, SIRT6 deacetylates STAT6 at lysine 284, thereby modulating the AF9/STAT6 signaling axis that governs purine metabolism and apoptosis [68] (Figure 4 and Table 1). This evidence concerns the gene STAT6 and clear cell renal carcinoma.